RenalytixAI Announces Closing of Global Offering and Resulting Total Voting Rights
21 juil. 2020 15h57 HE
|
Renalytix AI plc.
NEW YORK, July 21, 2020 (GLOBE NEWSWIRE) -- Renalytix AI plc (LSE: RENX) (NASDAQ: RNLX) (“RenalytixAI” or the “Company”), an artificial intelligence-enabled in vitro diagnostics company, focused on...
RenalytixAI Announces Pricing of Global Offering and Approval to List on the Nasdaq Global Market
16 juil. 2020 23h38 HE
|
Renalytix AI plc.
NEW YORK, July 16, 2020 (GLOBE NEWSWIRE) -- Renalytix AI plc (LSE: RENX) (“RenalytixAI” or the “Company”), an artificial intelligence-enabled in vitro diagnostics company, focused on optimizing...